2-147943530-GAAAAA-GAAAA
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_181741.4(ORC4):c.763-9del variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.50 ( 14965 hom., cov: 0)
Exomes 𝑓: 0.43 ( 5650 hom. )
Failed GnomAD Quality Control
Consequence
ORC4
NM_181741.4 splice_polypyrimidine_tract, intron
NM_181741.4 splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.108
Genes affected
ORC4 (HGNC:8490): (origin recognition complex subunit 4) The origin recognition complex (ORC) is a highly conserved six subunit protein complex essential for the initiation of the DNA replication in eukaryotic cells. Studies in yeast demonstrated that ORC binds specifically to origins of replication and serves as a platform for the assembly of additional initiation factors such as Cdc6 and Mcm proteins. This gene encodes a subunit of the ORC complex. Several alternatively spliced transcript variants, some of which encode the same protein, have been reported for this gene. [provided by RefSeq, Oct 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 2-147943530-GA-G is Benign according to our data. Variant chr2-147943530-GA-G is described in ClinVar as [Benign]. Clinvar id is 403280.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-147943530-GA-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.607 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ORC4 | NM_181741.4 | c.763-9del | splice_polypyrimidine_tract_variant, intron_variant | ENST00000392857.10 | NP_859525.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ORC4 | ENST00000392857.10 | c.763-9del | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_181741.4 | ENSP00000376597 | P1 |
Frequencies
GnomAD3 genomes AF: 0.499 AC: 65366AN: 131084Hom.: 14972 Cov.: 0
GnomAD3 genomes
AF:
AC:
65366
AN:
131084
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: InbreedingCoeff AF: 0.430 AC: 426378AN: 990950Hom.: 5650 Cov.: 0 AF XY: 0.433 AC XY: 218765AN XY: 505422
GnomAD4 exome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
AC:
426378
AN:
990950
Hom.:
Cov.:
0
AF XY:
AC XY:
218765
AN XY:
505422
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.499 AC: 65367AN: 131102Hom.: 14965 Cov.: 0 AF XY: 0.498 AC XY: 31508AN XY: 63274
GnomAD4 genome
AF:
AC:
65367
AN:
131102
Hom.:
Cov.:
0
AF XY:
AC XY:
31508
AN XY:
63274
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Meier-Gorlin syndrome 2 Benign:2
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 09, 2022 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 22, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at